<DOC>
	<DOCNO>NCT02113852</DOCNO>
	<brief_summary>This epidemiological , multicenter study genomic expression profile patient newly diagnose NSCLC.Two hundred fifty NSCLC patient fulfill criterion recruit investigational sites.Approximately 100 retrospectively collect sample detailed clinical 2-year follow-up information surgeries.The demographic , cancer/adjacent normal tissue match blood sample collect patient provide informed consent.All tissue sample analyze somatic mutation exome deep sequencing , mRNA expression profile RNA sequence chromosome copy number variation SNP array designate laboratory .</brief_summary>
	<brief_title>Study Blood , Tumor Adjacent Normal Tissue Samples From Chinese Smoking Induced Lung Cancer Patients</brief_title>
	<detailed_description>The 2-year follow-up information enrol patient collect every 6 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>1 . Provision write informed consent . 2 . Male female aged≥18 year . 3 . .Histological cytologically confirm primary NSCLC，including histological subtypes : adenocarcinoma , squamous cell carcinoma large cell carcinoma etc . 4 . .Provision surgical specimen blood sample.The retrospective sample collect 2006and 2012 biobank . 5 . Patients must willing provide detailed clinical information ( sex , age , geographic place , tumor stage , grade , size , smoke history , treatment history outcome data ) . 6 . Heavy smoker ( define smoke 20 packyears ) . 7 . Treatment naive patient : No prior chemotherapy , biological , immunological therapy radical radiotherapy permit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Non small cell Lung Cancer</keyword>
	<keyword>Heavy smoker</keyword>
	<keyword>Treatment naive patient</keyword>
</DOC>